AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Dose-Response Relationship, RadiationUltraviolet RaysRadiotherapy Planning, Computer-AssistedRadiotherapyNeoplasmsRadiotherapy DosageRadiation InjuriesRadiotherapy, ConformalRadiation OncologyRadiotherapy, Intensity-ModulatedRadiation DosageRadiotherapy, Computer-AssistedRadiometryRadiation, IonizingCarcinogensFiducial MarkersParticle AcceleratorsCombined Modality TherapyRadiotherapy, Image-GuidedRadiation ToleranceRadiotherapy, AdjuvantAneuploidyCell Transformation, NeoplasticHead and Neck NeoplasmsRadiationRadiation ProtectionTomography, X-Ray ComputedRadiation MonitoringRisk AssessmentRetrospective StudiesRadiotherapy, High-EnergyBrain NeoplasmsTreatment OutcomeDose FractionationRisk FactorsNeoplasms, Radiation-InducedPositron-Emission TomographyEarly Detection of CancerBreast NeoplasmsRadiation PneumonitisProstatic NeoplasmsLung NeoplasmsNeoplasm Recurrence, LocalNeoplasm StagingCarcinoma, Squamous CellReproducibility of ResultsAntineoplastic Combined Chemotherapy ProtocolsRadiation-Sensitizing AgentsSurvival RateAlgorithmsSurvival AnalysisRadiation Injuries, ExperimentalFollow-Up StudiesCosmic RadiationGamma RaysPrognosisDisease-Free SurvivalNeoplasm MetastasisAntineoplastic AgentsOvarian NeoplasmsBrachytherapyRectal NeoplasmsChemotherapy, AdjuvantUterine Cervical NeoplasmsStomach NeoplasmsMice, NudeRadiosurgeryNeoplasm InvasivenessColonic NeoplasmsPancreatic NeoplasmsCisplatinChemoradiotherapyCarcinoma, Non-Small-Cell LungRadiation-Protective AgentsCarcinomaCell Line, TumorBackground RadiationGene Expression Regulation, NeoplasticFluorouracilProspective StudiesNeoplasms, Second PrimaryRadiodermatitisCobalt RadioisotopesAdenocarcinomaCancer VaccinesCell SurvivalNeoplasm ProteinsRadiation EffectsDisease ProgressionTime FactorsRiskXenograft Model Antitumor AssaysSurvivorsOrgans at RiskDNA DamageTumor BurdenEsophageal NeoplasmsNasopharyngeal NeoplasmsCranial IrradiationProstate-Specific Antigen